GFAFX
Price
$76.26
Change
+$0.87 (+1.15%)
Updated
Jan 17 closing price
Net Assets
306.54B
JSGCX
Price
$24.82
Change
+$0.28 (+1.14%)
Updated
Jan 17 closing price
Net Assets
1.71B
Ad is loading...

GFAFX vs JSGCX

Header iconGFAFX vs JSGCX Comparison
Open Charts GFAFX vs JSGCXBanner chart's image
American Funds Growth Fund of Amer F1
Price$76.26
Change+$0.87 (+1.15%)
VolumeN/A
Net Assets306.54B
JHancock U.S. Growth C
Price$24.82
Change+$0.28 (+1.14%)
VolumeN/A
Net Assets1.71B
GFAFX vs JSGCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFAFX vs. JSGCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFAFX is a StrongBuy and JSGCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 307B vs. JSGCX (1.71B). GFAFX pays higher dividends than JSGCX: GFAFX (0.45) vs JSGCX (0.00). GFAFX was incepted earlier than JSGCX: GFAFX (24 years) vs JSGCX (10 years). JSGCX is a more actively managed with annual turnover of: 103.00 vs. GFAFX (31.00). GFAFX has a lower initial minimum investment than JSGCX: GFAFX (250) vs JSGCX (1000). GFAFX annual gain was more profitable for investors over the last year : 22.21 vs. JSGCX (18.19). GFAFX return over 5 years is better than : 45.81 vs. JSGCX (28.47).
GFAFXJSGCXGFAFX / JSGCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years10 years-
Gain YTD3.3892.098162%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets307B1.71B17,974%
Annual Yield % from dividends0.450.00-
Returns for 1 year22.2118.19122%
Returns for 3 years12.6711.85107%
Returns for 5 years45.8128.47161%
Returns for 10 years84.0158.59143%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEB13.750.05
+0.36%
Pebblebrook Hotel Trust
AZN66.60-0.31
-0.46%
AstraZeneca PLC
CRT10.28-0.05
-0.48%
Cross Timbers Royalty Trust
ARCT16.79-0.22
-1.29%
Arcturus Therapeutics Holdings
ASND128.13-3.49
-2.65%
Ascendis Pharma A/S